Literature DB >> 20941529

Mass spectrometry and biochemical analysis of RNA polymerase II: targeting by protein phosphatase-1.

Marina Jerebtsova1, Sergei A Klotchenko, Tatiana O Artamonova, Tatiana Ammosova, Kareem Washington, Vladimir V Egorov, Aram A Shaldzhyan, Maria V Sergeeva, Evgeny A Zatulovskiy, Olga A Temkina, Mikhail G Petukhov, Andrei V Vasin, Mikhail A Khodorkovskii, Yuri N Orlov, Sergei Nekhai.   

Abstract

Transcription of eukaryotic genes is regulated by phosphorylation of serine residues of heptapeptide repeats of the carboxy-terminal domain (CTD) of RNA polymerase II (RNAPII). We previously reported that protein phosphatase-1 (PP1) dephosphorylates RNAPII CTD in vitro and inhibition of nuclear PP1-blocked viral transcription. In this article, we analyzed the targeting of RNAPII by PP1 using biochemical and mass spectrometry analysis of RNAPII-associated regulatory subunits of PP1. Immunoblotting showed that PP1 co-elutes with RNAPII. Mass spectrometry approach showed the presence of U2 snRNP. Co-immunoprecipitation analysis points to NIPP1 and PNUTS as candidate regulatory subunits. Because NIPP1 was previously shown to target PP1 to U2 snRNP, we analyzed the effect of NIPP1 on RNAPII phosphorylation in cultured cells. Expression of mutant NIPP1 promoted RNAPII phosphorylation suggesting that the deregulation of cellular NIPP1/PP1 holoenzyme affects RNAPII phosphorylation and pointing to NIPP1 as a potential regulatory factor in RNAPII-mediated transcription.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20941529      PMCID: PMC3070240          DOI: 10.1007/s11010-010-0614-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  42 in total

1.  A cell-permeable peptide inhibits activation of PKR and enhances cell proliferation.

Authors:  S Nekhai; D P Bottaro; G Woldehawariat; A Spellerberg; R Petryshyn
Journal:  Peptides       Date:  2000-10       Impact factor: 3.750

2.  Opposing effects of Ctk1 kinase and Fcp1 phosphatase at Ser 2 of the RNA polymerase II C-terminal domain.

Authors:  E J Cho; M S Kobor; M Kim; J Greenblatt; S Buratowski
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

Review 3.  Control of RNA polymerase II activity by dedicated CTD kinases and phosphatases.

Authors:  B Majello; G Napolitano
Journal:  Front Biosci       Date:  2001-10-01

4.  Chromatin organization marks exon-intron structure.

Authors:  Schraga Schwartz; Eran Meshorer; Gil Ast
Journal:  Nat Struct Mol Biol       Date:  2009-09       Impact factor: 15.369

Review 5.  Modifications of RNA polymerase II are pivotal in regulating gene expression states.

Authors:  Emily Brookes; Ana Pombo
Journal:  EMBO Rep       Date:  2009-10-16       Impact factor: 8.807

6.  The C-terminus of NIPP1 (nuclear inhibitor of protein phosphatase-1) contains a novel binding site for protein phosphatase-1 that is controlled by tyrosine phosphorylation and RNA binding.

Authors:  M Beullens; V Vulsteke; A Van Eynde; I Jagiello; W Stalmans; M Bollen
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

7.  Identification and characterization of a novel human PP1 phosphatase complex.

Authors:  Jeong-Heon Lee; Jinsam You; Erika Dobrota; David G Skalnik
Journal:  J Biol Chem       Date:  2010-06-01       Impact factor: 5.157

8.  The phosphatase interactor NIPP1 regulates the occupancy of the histone methyltransferase EZH2 at Polycomb targets.

Authors:  Nele Van Dessel; Lijs Beke; Janina Görnemann; Nikki Minnebo; Monique Beullens; Nobuhiro Tanuma; Hiroshi Shima; Aleyde Van Eynde; Mathieu Bollen
Journal:  Nucleic Acids Res       Date:  2010-07-29       Impact factor: 16.971

9.  High-resolution mapping of the protein interaction network for the human transcription machinery and affinity purification of RNA polymerase II-associated complexes.

Authors:  Philippe Cloutier; Racha Al-Khoury; Mathieu Lavallée-Adam; Denis Faubert; Heng Jiang; Christian Poitras; Annie Bouchard; Diane Forget; Mathieu Blanchette; Benoit Coulombe
Journal:  Methods       Date:  2009-05-18       Impact factor: 3.608

10.  Protein phosphatase 1 regulates the histone code for long-term memory.

Authors:  Kyoko Koshibu; Johannes Gräff; Monique Beullens; Fabrice D Heitz; Dominik Berchtold; Holger Russig; Mélissa Farinelli; Mathieu Bollen; Isabelle M Mansuy
Journal:  J Neurosci       Date:  2009-10-14       Impact factor: 6.167

View more
  14 in total

1.  Expression of a protein phosphatase 1 inhibitor, cdNIPP1, increases CDK9 threonine 186 phosphorylation and inhibits HIV-1 transcription.

Authors:  Tatiana Ammosova; Venkat R K Yedavalli; Xiaomei Niu; Marina Jerebtsova; Aleyde Van Eynde; Monique Beullens; Mathieu Bollen; Kuan-Teh Jeang; Sergei Nekhai
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

2.  Magnetic labeling of proteins for atomic force microscopy.

Authors:  V V Egorov; Y A Zabrodskaya; A S Kalinin; D V Lebedev; N A Grudinina; A V Vasin; V A Kolikov; S A Klotchenko; M M Shawlovsky; Ph G Rutberg
Journal:  Dokl Biochem Biophys       Date:  2013-03-13       Impact factor: 0.788

Review 3.  MYC protein interactors in gene transcription and cancer.

Authors:  Diana Resetca; Cornelia Redel; Corey Lourenco; Peter Lin; Alannah S MacDonald; Roberto Ciaccio; Tristan M G Kenney; Yong Wei; David W Andrews; Maria Sunnerhagen; Cheryl H Arrowsmith; Brian Raught; Linda Z Penn
Journal:  Nat Rev Cancer       Date:  2021-06-29       Impact factor: 60.716

4.  Phosphatase 1 nuclear targeting subunit is an essential regulator of M-phase entry, maintenance, and exit.

Authors:  Laura A Fisher; Ling Wang; Lan Wu; Aimin Peng
Journal:  J Biol Chem       Date:  2014-07-07       Impact factor: 5.157

5.  Understanding the antagonism of retinoblastoma protein dephosphorylation by PNUTS provides insights into the PP1 regulatory code.

Authors:  Meng S Choy; Martina Hieke; Ganesan Senthil Kumar; Greyson R Lewis; Kristofer R Gonzalez-DeWhitt; Rene P Kessler; Benjamin J Stein; Manuel Hessenberger; Angus C Nairn; Wolfgang Peti; Rebecca Page
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-03       Impact factor: 11.205

Review 6.  Protein Phosphatase-1 -targeted Small Molecules, Iron Chelators and Curcumin Analogs as HIV-1 Antivirals.

Authors:  Xionghao Lin; Tatyana Ammosova; Namita Kumari; Sergei Nekhai
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

7.  Small molecules targeted to a non-catalytic "RVxF" binding site of protein phosphatase-1 inhibit HIV-1.

Authors:  Tatiana Ammosova; Maxim Platonov; Venkat R K Yedavalli; Yuri Obukhov; Victor R Gordeuk; Kuan-Teh Jeang; Dmytro Kovalskyy; Sergei Nekhai
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

8.  Genome-wide promoter binding profiling of protein phosphatase-1 and its major nuclear targeting subunits.

Authors:  Toon Verheyen; Janina Görnemann; Iris Verbinnen; Shannah Boens; Monique Beullens; Aleyde Van Eynde; Mathieu Bollen
Journal:  Nucleic Acids Res       Date:  2015-05-18       Impact factor: 16.971

9.  PNUTS/PP1 regulates RNAPII-mediated gene expression and is necessary for developmental growth.

Authors:  Anita Ciurciu; Louise Duncalf; Vincent Jonchere; Nick Lansdale; Olga Vasieva; Peter Glenday; Andreii Rudenko; Emese Vissi; Neville Cobbe; Luke Alphey; Daimark Bennett
Journal:  PLoS Genet       Date:  2013-10-31       Impact factor: 5.917

10.  Protein Phosphatase-1 Regulates Expression of Neuregulin-1.

Authors:  Tatiana Ammosova; Kareem Washington; Jamie Rotimi; Namita Kumari; Kahli A Smith; Xiaomei Niu; Marina Jerebtsova; Sergei Nekhai
Journal:  Biology (Basel)       Date:  2016-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.